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Comprising the most extensive component 
of the human lymphatic system, mucosa-
associated lymphoid tissue (MALT) 
is a protective system of extra-nodal 
lymphoid cells distributed throughout 
the body.1 Malignancies that develop 
within these tissues are regarded as 
extra-nodal marginal zone lymphoma 
of mucosa-associated lymphoid tissue 
(MALT lymphoma) and represent about 
8% of all non-Hodgkin lymphomas.2,3 
Most MALT lymphomas develop within 
the stomach and have been associated 
with chronic inflammation from infectious 
or autoimmune etiologies.3 Fewer than 
30% are noted to arise from within the 
small intestine.3 Helicobacter pylori (H. 
pylori) has been a well described risk 
factor for the development of gastric MALT 
lymphomas, however it’s role in duodenal 
disease is unclear as only a limited 
number or reports have been described.4 
We present a unique case in which a 
MALT lymphoma, discovered within the 
duodenum, developed from a duodenal 
ulcer in the absence of autoimmune or 
infectious causes.  
•  Primary duodenal MALT lymphoma is exceedingly rare with a small number of case reports 19954
•  Symptoms of gastrointestinal MALT Lymphoma are dependent on location of growth however may include:
   –  Indigestion, abdominal pain
   –  Night sweats, weight loss, low grade fevers
   –  Iron deficiency anemia, melena
   –  Constipation and even bowel obstruction in severe cases
•  Diagnosis is made endoscopically with biopsies revealing:
   –  Massive lymphomatous infiltration of CD20+ neoplastic cells within lymphoid follicles5
•  The role of autoimmune diseases and H. pylori has been clearly established in gastric disease however is 
unclear in duodenal manifestations. 
   –  Few studies have reported regression following treatment in H. pylori positive cases6
   –  Few studies have reported remission with combination chemotherapy including CVP (cyclophosphamide, 
vincristine, and prednisolone) and rituximab3,8
•  In our case report, we have presented the progression of a duodenal ulceration to a MALT lymphoma
   –  Duodenal ulcerations in itself may represent a significant risk factor for MALT lymphoma development
•  Clinical experience and judgment is crucial in its diagnosis. Although duodenal ulceration does not currently 
require follow up endoscopy, unusual or atypical appearing lesions should always be investigated with biopsy 
and followed clinically for resolution.  
DISCUSSION
A 56-year-old male with a medical history of hypertension presented to his primary care doctor for 
evaluation of progressive fatigue and melena over the previous few weeks. Laboratory data revealed a 
microcytic anemia with a hemoglobin of 6.6 g/dL. Initial upper endoscopy revealed a large white based 
non-bleeding ulcer with heaped edges within the second portion of the duodenum (Figure 1). Duodenal 
biopsies revealed active chronic duodenitis with evidence of gastric metaplasia. Antral biopsies were 
performed and H.pylori staining was negative. Computed tomography of the abdomen and pelvis revealed 
wall-thickening of the junction of the second and third portions of the duodenum. He was started on a 
proton pump inhibitor. Follow up endoscopy 3 months later revealed persistence of the duodenal lesion 
with a new nodularity component (Figure 2). Repeat biopsy was consistent with a MALT lymphoma (Figure 
3). Follow up positron emission tomography (PET) scan and bone marrow biopsy revealed stage 1E 
disease without evidence of lymph node involvement or metastasis. He completed 4 cycles of rituximab 
therapy with follow up PET scan revealing partial tumor regression. 
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Figure 1: Initial EGD revealing a large white based ulcer with heaped edges 
within the second portion of the duodenun. 
Figure 2: Repeat Endoscopy 3months later revealing development of duodenal 
lesion with nodularity component.
Figure 3: Endoscopic biopsy of duodenal mass revealing dense infiltration of glandular tissue by 
lymphoid neoplastic cells.
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